ACADIA Pharmaceuticals
ACAD
#3710
Rank
A$5.35 B
Marketcap
A$31.00
Share price
0.82%
Change (1 day)
-9.25%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): A-$1.39

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$3.26. In 2022 the company made an earnings per share (EPS) of A-$1.94 a decrease over its 2021 EPS that were of A-$1.52.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$1.39-28.25%
2022A-$1.9427.62%
2021A-$1.52-41.67%
2020A-$2.6112.5%
2019A-$2.32-17.95%
2018A-$2.82-17.02%
2017A-$3.400.43%
2016A-$3.3943.56%
2015A-$2.3673.4%
2014A-$1.36113.64%
2013A-$0.6418.92%
2012A-$0.54-15.91%
2011A-$0.64-210%
2010A$0.58-133.61%
2009A-$1.72-30.81%
2008A-$2.497.5%
2007A-$2.32-0.62%
2006A-$2.334.55%
2005A-$2.23-14.61%
2004A-$2.61-84.26%
2003A-$16.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.68 197.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.10-66.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.71 1,271.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.55 100.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
A-$6.71-305.78%๐Ÿ‡บ๐Ÿ‡ธ USA